Over-the-counter antifungal creams and suppositories can start relieving symptoms within hours, and a single oral prescription pill works just as fast for most people. The fastest path depends on whether you have access to a pharmacy right now, whether you’re pregnant, and whether this is your first infection or a recurring one. Getting the right treatment matters, though, because a surprising number of people who think they have a yeast infection actually have something else entirely.
Make Sure It’s Actually a Yeast Infection
This step feels annoying when you’re uncomfortable and just want relief, but it’s the single most important thing you can do to speed up your recovery. Bacterial vaginosis, trichomoniasis, contact dermatitis, and even some sexually transmitted infections can look and feel like a yeast infection. If you treat the wrong condition with an antifungal, you waste days while the real problem gets worse. Research consistently shows that women tend to be knowledgeable about yeast infections but have low awareness of bacterial vaginosis, which leads to considerable self-misdiagnosis in countries where antifungal treatments are available over the counter.1Journal of Lower Genital Tract Disease. Attitudes and Experience of Women to Common Vaginal Infections
If you’ve had a confirmed yeast infection before and the symptoms are unmistakable to you, self-treating with an OTC antifungal is reasonable. If this is your first time, if the symptoms are different from previous infections, or if you’ve recently treated what you thought was a yeast infection and it didn’t go away, see a healthcare provider. A simple vaginal pH test can help narrow things down: yeast infections typically keep vaginal pH at or below 4.5, while bacterial vaginosis and trichomoniasis tend to raise it. One study found that limiting OTC antifungal use to people with symptoms and a vaginal pH of 4.5 or lower cut inappropriate use by roughly half.2PubMed Central. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device
Over-the-Counter Antifungals and How Quickly They Work
The fastest OTC option for most people is a topical azole antifungal, the class of drugs that includes clotrimazole (Gyne-Lotrimin), miconazole (Monistat), and tioconazole (Vagistat-1). These come as creams, suppositories, or combination packs. They have a proven cure rate in the range of 85% to 90% for vaginal yeast infections, and the most common side effects are mild local reactions like stinging or burning, occurring in about 7% of users.3JAMA & Archives (Archives of Family Medicine). The “Prescription-to-OTC Switch” Movement: Its Effects on Antifungal Vaginitis Preparations
How you choose between them comes down to how many days you’re willing to use the product. Regimens range from a single-dose insert to seven-day treatments. Shorter courses are more convenient but tend to use a higher concentration of the drug. All of them reach the same destination in the end. When researchers compared once-daily versus twice-daily applications of tioconazole cream, both schedules achieved clinical response rates above 95%, with no meaningful difference in effectiveness or tolerability.4PubMed. A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream
The key question for someone who wants relief “ASAP” is: how soon will the itching and burning stop? A trial comparing butoconazole vaginal cream to oral fluconazole found that topical butoconazole provided first symptom relief at a median of about 17.5 hours, compared to about 23 hours for oral fluconazole. By 24 hours after treatment, roughly 73% of the topical cream group reported some relief, versus about 56% of the oral pill group.5Infectious Diseases in Obstetrics and Gynecology. An Evaluation of Butoconazole Nitrate 2% Site Release Vaginal Cream (Gynazole-1) Compared to Fluconazole 150 mg Tablets (Diflucan) in the Time to Relief of Symptoms in Patients With Vulvovaginal Candidiasis That said, the total time to complete resolution of symptoms was similar for both groups, and reinfection rates at 30 days were the same. So topical creams give you a head start on comfort, but the pill catches up.
Prescription Options
Fluconazole (Diflucan) is the most commonly prescribed oral antifungal for yeast infections. A single 150 mg pill is the standard dose, and for many people it’s the most convenient option: no messy creams, no multi-day regimen. Its main appeal is simplicity. Its main drawback is that it takes a few hours longer to provide initial symptom relief compared to topical treatments applied directly to the affected area, as the drug needs to be absorbed through your gut and distributed through your bloodstream first.
If you’re already seeing a healthcare provider for your symptoms, getting a fluconazole prescription is often the fastest overall path because the visit itself can rule out other conditions. Many providers will call it in to a pharmacy based on a phone or telehealth visit, especially for people with a clear history of yeast infections.
Newer Prescription Antifungals
Ibrexafungerp (Brexafemme) is the first drug in a new class of antifungals approved for vaginal yeast infections. It works by a different mechanism than azoles, which makes it a meaningful option for infections caused by yeast species that have developed resistance to older drugs. In a phase 2 trial, ibrexafungerp matched fluconazole in clinical cure rates at the initial follow-up, with about 52% versus 58% of patients cured. Where it looked promising was at the later 25-day mark, when about 70% of ibrexafungerp patients had improved symptoms compared to roughly 58% on fluconazole.6Clinical Infectious Diseases. Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis For a first-time, straightforward yeast infection, ibrexafungerp is probably not your first-line pick. But if you’ve had infections that didn’t respond to fluconazole, it’s worth asking your provider about.
When Standard Treatments Don’t Work
Not all yeast infections are caused by the same organism. The vast majority are caused by Candida albicans, which responds well to the standard azole drugs. But a meaningful minority are caused by other species, particularly Candida glabrata, which is naturally less susceptible to fluconazole. Non-albicans species are becoming more of a concern: a recent global analysis found pooled fluconazole resistance rates of about 16% for C. glabrata and 78% for C. krusei, with substantial variation by region.7PubMed Central. Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis The trend is driven in part by cell wall and membrane changes in these species that make azole drugs less effective.8Journal of Antimicrobial Chemotherapy. Drug resistance mechanisms and their regulation in non-albicans Candida species
If your infection doesn’t clear after a full course of an azole antifungal, your provider may culture the yeast to identify which species is causing the problem. This is when boric acid vaginal suppositories often enter the conversation. Boric acid has been used for decades and is particularly useful against C. glabrata. In a study of women with diabetes and C. glabrata infections, boric acid achieved a cure rate of roughly 64% to 72%, compared to about 29% to 33% with fluconazole.9Diabetes Care. Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis A separate multi-center study using 600 mg boric acid daily for two to three weeks found clinical and mycological success in 64% to 71% of women with symptomatic C. glabrata infections.10PubMed. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine
An important caution: boric acid suppositories are for vaginal use only and are toxic if swallowed. They should not be used during pregnancy. They are not a first-line treatment for a standard yeast infection; they’re a second-line option specifically for resistant or non-albicans species, and ideally should be used with guidance from a healthcare provider.
What About Probiotics and Natural Remedies?
Probiotics are heavily marketed for vaginal health, and there’s a kernel of truth behind the hype, but the evidence is more limited than the packaging suggests. A meta-analysis looking at probiotics for yeast infections found that probiotics alone were no better than placebo at clearing a positive yeast culture. However, when probiotics were combined with standard azole therapy, the combination was more effective than azoles alone at reducing positive cultures and clinical symptoms.11PubMed Central. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis The probiotics also appeared to reduce recurrence rates compared to placebo. So probiotics might be a useful add-on, but they’re not a standalone treatment for an active infection.
A review of the clinical trial evidence on specific probiotic strains noted that some results were encouraging, particularly for Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14, but most of the trials had small sample sizes, lacked placebo controls, or included women who didn’t have confirmed recurrent infections.12Journal of Antimicrobial Chemotherapy. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review In short, if you’re already treating with an antifungal and want to add a probiotic, it probably won’t hurt and might help prevent the next episode. But popping a probiotic capsule instead of using an antifungal will not get rid of your current infection any faster.
As for other natural remedies, a systematic review of complementary therapies for vaginal infections found that tea tree oil and garlic showed some antifungal activity in laboratory settings, but no human studies supported recommending them to patients. Vaginal douching, meanwhile, was associated with risks and showed no documented clinical benefit for treating vaginitis.13Obstetrical & Gynecological Survey. Common Complementary and Alternative Therapies for Yeast Vaginitis and Bacterial Vaginosis: A Systematic Review Coconut oil, yogurt applied topically, and apple cider vinegar baths are popular internet suggestions that lack clinical evidence. Using unproven remedies delays effective treatment and may irritate already inflamed tissue.
Yeast Infections During Pregnancy
Pregnancy changes both the treatment approach and the urgency. Yeast infections are more common during pregnancy due to hormonal shifts, and the treatment options narrow because oral antifungals carry some risk. Topical azole antifungals are the recommended treatment during pregnancy, used for at least seven days rather than the shorter courses that non-pregnant people can use.14PubMed Central. Vaginal yeast infections during pregnancy The longer course is needed because shorter regimens are less effective in pregnant women.
A Cochrane review found that imidazole-class drugs (like clotrimazole and miconazole) were substantially more effective than nystatin during pregnancy, and that four-day courses were less effective than seven-day courses.15Cochrane Database of Systematic Reviews. Topical treatments for vaginal candidiasis (thrush) in pregnancy So if you’re pregnant and trying to get rid of a yeast infection quickly, a seven-day topical azole is the way to go. While topical azoles are considered safe in pregnancy, systemic (oral) azoles like fluconazole carry some data suggesting a dose-related increase in the risk of birth defects.16PubMed. Antifungal drugs in pregnancy: a review Most guidelines advise avoiding oral fluconazole during pregnancy, especially in the first trimester.
Dealing With Recurrent Infections
Recurrent vulvovaginal candidiasis is generally defined as four or more confirmed episodes within a year. If that describes your situation, treating each episode individually won’t solve the underlying problem. The standard approach is suppressive therapy: after clearing the current infection, you take a weekly dose of fluconazole for six months to keep the yeast from bouncing back.
This strategy works well while you’re on it. A landmark trial found that about 91% of women on weekly fluconazole remained infection-free at six months, compared to about 36% on placebo. The median time to recurrence was over 10 months in the treatment group versus 4 months for placebo.17PubMed. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis The catch is what happens after you stop: by 12 months, about 57% of the fluconazole group had relapsed. The infection suppression is real, but it doesn’t permanently change the underlying susceptibility for many people.
One approach to this problem is an individualized tapering regimen, where the dose frequency is gradually reduced rather than stopped abruptly. A study of 136 women using a personalized decreasing-dose fluconazole schedule found it effective at preventing clinical relapses.18American Journal of Obstetrics & Gynecology. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis Another group using fluconazole combined with probiotics found that after completing the full maintenance course, only about 10% of patients experienced symptoms that could be related to recurrence during follow-up.19PubMed Central. The Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol If you’re stuck in a cycle of repeated infections, working with a provider to find the right maintenance strategy is far more effective than treating each flare-up as a one-off.
Does Treating Your Partner Help?
This is one of the most persistent myths in yeast infection management. It seems logical that if your partner carries the same yeast, you’d just keep passing it back and forth. But multiple controlled trials have tested this directly, and the answer is consistent: treating the male partner does not improve cure rates or reduce recurrence in women with vaginal yeast infections.
A double-blind randomized study found no difference in cure or recurrence rates regardless of whether the male partner received antifungal treatment.20PubMed. Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study A separate trial looking specifically at recurrent infections reached the same conclusion: about 82% of women recurred within a year whether or not their male partners were treated, and the researchers noted it was unlikely a larger study would show a meaningful difference.21Sexually Transmitted Infections. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole Yet another trial confirmed the same pattern.22PubMed. The value of treating the male partner in vaginal candidiasis
Yeast infections are not considered sexually transmitted, even though Candida can be found on the genitals of sexual partners. The recurrence is driven by factors within the vaginal environment itself, not by reinfection from a partner. If your partner has symptoms of their own (redness, irritation, or itching on the penis), they should be evaluated and treated for their own comfort, but doing so won’t prevent your infections from coming back.
Common Triggers and What Actually Helps Prevent Infections
Understanding what triggers yeast infections gives you some control over preventing the next one. The most well-established trigger is antibiotic use. Antibiotics reduce or alter the vaginal bacterial community that normally keeps yeast in check, allowing Candida to proliferate and cause symptoms.23PubMed. Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure If you notice yeast infections tend to follow courses of antibiotics, that’s one of the scenarios where a prophylactic dose of fluconazole alongside the antibiotic might be worth discussing with your provider.
Other commonly cited triggers include elevated blood sugar (people with poorly controlled diabetes are at higher risk), hormonal changes from pregnancy or oral contraceptives, and immunosuppression. Clothing and hygiene habits tend to get a lot of attention in popular advice, and there may be something to the underwear question. A small prospective study found that women who switched to antimicrobial underwear for a trial period saw the proportion of negative vaginal cultures rise from 40% to 80%, with Candida species markedly reduced.24PubMed Central. Effects of Antimicrobial Underwear on Vaginal Symptoms and Vaginal Microbiota: A Prospective Study That’s a single small study and shouldn’t be treated as definitive, but it aligns with the general advice to keep the vulvar area dry and avoid non-breathable fabrics.
A Note on Vaginal Gels and Washes
Many over-the-counter vaginal gels marketed for “pH balance” or “freshness” can actually make things worse. A laboratory study evaluating 11 commercially available vaginal gels, including nine containing lactic acid, found that ten of them had osmolality levels far higher than normal vaginal fluid. When tested on a model of vaginal tissue, the highly concentrated gels caused substantial cell damage, reducing cell viability to less than 10% compared to untreated cells, and triggered the release of inflammatory markers.25PubMed Central. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium in vitro The inflammation and tissue disruption these products cause can make the vaginal lining more vulnerable to infection rather than less. If you’re dealing with recurrent yeast infections, adding washes and gels to the mix is more likely to perpetuate the cycle than break it. The vagina is self-cleaning; warm water externally is generally all you need for hygiene.